Summary of gastroscopy quality indicators applicable in clinical practice
- PMID: 41081082
- PMCID: PMC12508386
- DOI: 10.5114/pg.2025.154599
Summary of gastroscopy quality indicators applicable in clinical practice
Abstract
Despite advances in medicine, upper gastrointestinal cancers remain a significant global concern. In Poland, regardless of the increase in performed esophagogastroduodenoscopies, the rate of missed cancers is around 6%. This is related to the insufficient quality measures during the performed examinations. Our paper discusses key endoscopy quality indicators that can enhance the detection of precancerous lesions and cancers. We categorized the indicators into three sections: pre-procedural (fasting time, premedication), intra-procedural (sedation, photodocumentation, virtual chromoendoscopy, quality metrics, biopsy sampling) and post-procedural (coordinated care, training). Some of them, such as chromoendoscopy and premedication in the upper segment, have been widely studied and popularized in recent years. For several years, we have had strict protocols on how to take specimens depending on the condition. Most of the assumptions presented can be easily implemented into daily routine practice, which can improve health care. These are successfully, routinely used in Japan and Korea. We believe that a collective improvement in the quality of esophagogastroduodenoscopies performed will increase the detection rates of precancerous lesions and early cancers. However, further research in this area is still needed.
Keywords: esophageal cancer; esophagogastroduodenoscopy; gastric cancer; quality indicators.
Copyright © 2025 Termedia.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-63. - PubMed
-
- Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365-88. - PubMed
-
- Pimenta-Melo AR, Monteiro-Soares M, Libânio D, Dinis-Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2016; 28: 1041-9. - PubMed
-
- Januszewicz W, Witczak K, Wieszczy P, et al. Prevalence and risk factors of upper gastrointestinal cancers missed during endoscopy: a nationwide registry-based study. Endoscopy 2022; 54: 653-60. - PubMed
Publication types
LinkOut - more resources
Full Text Sources